Compare Stocks → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:CIMNYSE:CLNYNYSE:EQCNYSE:NHINYSE:SITC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCIMChimera Investment$4.14-0.5%$4.36$3.92▼$6.49$999.89M1.681.84 million shs104,744 shsCLNYColony Capital$7.34$1.73▼$8.70$4.14B1.953.86 million shs258,461 shsEQCEquity Commonwealth$18.60-0.3%$18.71$17.93▼$21.49$1.99B0.24898,659 shs20,961 shsNHINational Health Investors$62.40-0.7%$59.38$47.54▼$63.19$2.71B0.95170,477 shs599 shsSITCSITE Centers$13.69-0.5%$14.00$10.88▼$14.71$2.87B1.582.03 million shs7,472 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCIMChimera Investment-0.24%+4.79%-8.07%-16.30%-24.77%CLNYColony Capital0.00%0.00%0.00%0.00%0.00%EQCEquity Commonwealth+0.27%+0.65%-0.67%-2.51%-8.80%NHINational Health Investors+0.22%+5.45%+2.04%+16.28%+28.58%SITCSITE Centers-0.11%+2.46%-2.06%-0.69%+12.69%Just Released: Insider's Secret to Trading Options (Ad)This Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today.Yes! Show Me This StrategyMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCIMChimera Investment4.7289 of 5 stars3.03.01.73.22.40.83.8CLNYColony CapitalN/AN/AN/AN/AN/AN/AN/AN/AEQCEquity Commonwealth1.8018 of 5 stars0.03.00.00.02.82.51.9NHINational Health Investors4.5231 of 5 stars2.34.01.74.12.43.31.9SITCSITE Centers2.8247 of 5 stars1.35.03.30.03.32.51.3Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCIMChimera Investment2.00Hold$5.5032.85% UpsideCLNYColony CapitalN/AN/AN/AN/AEQCEquity CommonwealthN/AN/AN/AN/ANHINational Health Investors2.50Moderate Buy$60.50-3.04% DownsideSITCSITE Centers2.50Moderate Buy$14.254.09% UpsideCurrent Analyst RatingsLatest CLNY, CIM, SITC, NHI, and EQC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/4/2024NHINational Health InvestorsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$55.00 ➝ $58.004/1/2024SITCSITE CentersWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$15.503/18/2024NHINational Health InvestorsWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$64.00 ➝ $66.003/12/2024NHINational Health InvestorsBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$67.002/26/2024NHINational Health InvestorsWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Outperform$57.00 ➝ $64.002/26/2024NHINational Health InvestorsWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$55.00 ➝ $63.001/30/2024NHINational Health InvestorsDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$69.00(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCIMChimera Investment$772.90M1.29$1.05 per share3.93$11.28 per share0.37CLNYColony Capital$1.24B0.00N/AN/A$12.36 per share0.00EQCEquity Commonwealth$60.52M32.88$1.02 per share18.27$21.28 per share0.87NHINational Health Investors$319.83M8.47$4.87 per share12.82$29.13 per share2.14SITCSITE Centers$539.46M5.31$2.29 per share5.98$9.56 per share1.43Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCIMChimera Investment$126.10M$0.2318.007.26N/A16.32%7.51%1.44%5/2/2024 (Estimated)CLNYColony Capital-$2.68B$0.09N/A0.00N/A-192.01%-41.20%-12.51%N/AEQCEquity Commonwealth$91.16M$0.7624.47∞N/A150.62%4.04%3.78%5/1/2024 (Confirmed)NHINational Health Investors$135.65M$3.1319.9413.74N/A42.40%10.65%5.41%5/6/2024 (Confirmed)SITCSITE Centers$265.70M$1.2111.3117.33N/A49.25%14.00%6.56%4/30/2024 (Confirmed)Latest CLNY, CIM, SITC, NHI, and EQC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2024N/ANHINational Health Investors$1.06N/A-$1.06N/AN/AN/A 5/1/2024N/AEQCEquity CommonwealthN/AN/AN/AN/AN/AN/A 4/30/2024N/ASITCSITE Centers$0.24N/A-$0.24N/AN/AN/A 2/13/202412/31/2023SITCSITE Centers$0.26$0.92+$0.66$0.92$127.81 million$123.20 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCIMChimera Investment$0.4410.63%-20.63%191.30%N/ACLNYColony Capital$0.44N/AN/A488.89%N/AEQCEquity CommonwealthN/AN/AN/AN/AN/ANHINational Health Investors$3.605.77%-6.54%115.02%N/ASITCSITE Centers$0.523.80%+27.65%42.98%N/ALatest CLNY, CIM, SITC, NHI, and EQC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/20/2024NHINational Health InvestorsQuarterly$0.906.34%3/27/20243/28/20245/3/20243/28/2024CIMChimera Investmentquarterly$0.119.54%4/5/20244/8/20244/30/20242/13/2024SITCSITE CentersQuarterly$0.133.69%3/13/20243/14/20244/5/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCIMChimera Investment3.000.120.12CLNYColony Capital1.290.960.96EQCEquity CommonwealthN/A79.7279.72NHINational Health Investors0.9010.2710.27SITCSITE Centers0.813.243.24OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCIMChimera Investment48.44%CLNYColony Capital82.66%EQCEquity Commonwealth96.00%NHINational Health Investors62.51%SITCSITE Centers88.70%Insider OwnershipCompanyInsider OwnershipCIMChimera Investment0.74%CLNYColony Capital9.59%EQCEquity Commonwealth2.80%NHINational Health Investors7.26%SITCSITE Centers10.10%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCIMChimera Investment39241.52 million239.58 millionOptionableCLNYColony Capital300487.16 millionN/AOptionableEQCEquity Commonwealth22106.99 million104.00 millionOptionableNHINational Health Investors2643.42 million40.27 millionOptionableSITCSITE Centers220209.36 million188.21 millionOptionableCLNY, CIM, SITC, NHI, and EQC HeadlinesSourceHeadlineGov. Kotek to propose federal technical center at Intel's Hillsboro complexmsn.com - April 23 at 1:22 PMSurprise City Center project has big plans to transform the areamsn.com - April 23 at 1:22 PMSITE Centers (SITC) to Release Quarterly Earnings on Tuesdaymarketbeat.com - April 23 at 6:15 AMLouisiana State Employees Retirement System Takes $1.23 Million Position in SITE Centers Corp. (NYSE:SITC)marketbeat.com - April 23 at 4:51 AMOVERSEA CHINESE BANKING Corp Ltd Raises Stock Position in SITE Centers Corp. (NYSE:SITC)marketbeat.com - April 21 at 11:34 AMSITE Centers Corp. (NYSE:SITC) Shares Sold by Strs Ohiomarketbeat.com - April 19 at 5:45 AMSITE Centers’ First Quarter 2024 Earnings Conference Call to be Held on Tuesday, April 30, 2024, at 8:00 a.m. Eastern Timefinance.yahoo.com - April 15 at 5:11 PMSITE Centers' First Quarter 2024 Earnings Conference Call to be Held on Tuesday, April 30, 2024, at 8:00 a.m. Eastern Timebusinesswire.com - April 15 at 4:15 PMSacramento City Council discusses vacant Meadowview site 2 years after paying $12.3 million for itcapradio.org - April 11 at 10:14 AMPeregrine Capital Management LLC Trims Holdings in SITE Centers Corp. (NYSE:SITC)marketbeat.com - April 11 at 7:49 AMSITC Quantitative Stock Analysis - Peter Lynchnasdaq.com - April 8 at 9:41 AMOfficials tour of Florida's Urban Search and Rescue Task Force 2 training centercbsnews.com - April 8 at 12:45 AM8 remain missing after ship collision in South Chinachinadaily.com.cn - April 8 at 12:45 AMBriefly: April 8chinadaily.com.cn - April 8 at 12:45 AMSITE Centers Corp SITCmorningstar.com - April 5 at 6:57 PMCity Council takes next step toward residential development at Cumming City Centerforsythnews.com - April 3 at 6:35 PMDemolition now underway at future site of Inch & Co. sports complex in York Countymsn.com - April 3 at 6:35 PMLCCC becomes NextFlex Education and Workforce Development Innovation Centermsn.com - April 2 at 4:14 PMTechnology Research Corp. signs 10-year lease at St. Pete’s Baypoint Commerce Centerbizjournals.com - April 1 at 7:05 PMThe Surprise City Center project's first three buildings are slated to be completed this summermsn.com - April 1 at 2:05 PMSITE Centers (NYSE:SITC) Earns "Overweight" Rating from Wells Fargo & Companymarketbeat.com - April 1 at 12:23 PMNew center created to oversee campus construction and renovationjhunewsletter.com - April 1 at 9:04 AMCrestview moving ahead on athletic project centersalemnews.net - April 1 at 4:03 AMCrestview moves ahead on athletic project centermorningjournalnews.com - April 1 at 4:03 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsChimera InvestmentNYSE:CIMChimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities. It invests in investment grade, non-investment grade, and non-rated classes. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. As a REIT, it intends to distribute at least 90% of its taxable income as dividends to shareholders. Chimera Investment Corporation was incorporated in 2007 and is headquartered in New York, New York.Colony CapitalNYSE:CLNYColony Capital, Inc. (NYSE: CLNY) is a leading global investment firm with a heritage of identifying and capitalizing on key secular trends in real estate. The Company manages an approximately $47 billion portfolio of real assets on behalf of its shareholders and limited partners, including over $23 billion in digital real estate investments through Digital Colony, its digital infrastructure platform. Colony Capital, structured as a REIT, is headquartered in Los Angeles with key offices in Boca Raton, New York, and London, and has over 350 employees across 20 locations in 11 countries.Equity CommonwealthNYSE:EQCEquity Commonwealth (NYSE: EQC) is a Chicago based, internally managed and self-advised real estate investment trust (REIT) with commercial office properties in the United States. EQC's portfolio is comprised of four properties totaling 1.5 million square feet.National Health InvestorsNYSE:NHIIncorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.SITE CentersNYSE:SITCSITE Centers is an owner and manager of open-air shopping centers located in suburban, high household income communities. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.